SEPN
Price:
$26.16
Market Cap:
$1.17B
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was form...[Read more]
Industry
Biotechnology
IPO Date
2024-10-25
Stock Exchange
NASDAQ
Ticker
SEPN
According to Septerna, Inc.’s latest financial reports and current stock price. The company's current ROE is -14.83%. This represents a change of 301.75% compared to the average of -3.69% of the last 4 quarters.
The mean historical ROE of Septerna, Inc. over the last ten years is 11.54%. The current -14.83% ROE has changed -228.45% with respect to the historical average. Over the past ten years (40 quarters), SEPN's ROE was at its highest in in the June 2024 quarter at 24.26%. The ROE was at its lowest in in the December 2023 quarter at -90.93%.
Average
11.54%
Median
-10.89%
Minimum
-17.09%
Maximum
62.61%
Discovering the peaks and valleys of Septerna, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 56.92%
Maximum Annual ROE = 62.61%
Minimum Annual Increase = -117.40%
Minimum Annual ROE = -17.09%
| Year | ROE | Change |
|---|---|---|
| 2024 | -17.09% | 56.92% |
| 2023 | -10.89% | -117.40% |
The current ROE of Septerna, Inc. (SEPN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.54%
5-year avg
11.54%
10-year avg
11.54%
Septerna, Inc.’s ROE is greater than Bicara Therapeutics Inc. Common Stock (-21.67%), greater than Tango Therapeutics, Inc. (-79.72%), greater than Fortrea Holdings Inc. (-119.71%), greater than Prime Medicine, Inc. (-163.51%), greater than Kura Oncology, Inc. (-65.42%), greater than EyePoint Pharmaceuticals, Inc. (-76.13%), less than ProKidney Corp. (11.01%), greater than Maravai LifeSciences Holdings, Inc. (-42.64%), greater than Nurix Therapeutics, Inc. (-53.57%), greater than Arbutus Biopharma Corporation (-50.20%),
| Company | ROE | Market cap |
|---|---|---|
| -21.67% | $1.03B | |
| -79.72% | $1.09B | |
| -119.71% | $1.31B | |
| -163.51% | $681.46M | |
| -65.42% | $1.04B | |
| -76.13% | $1.15B | |
| 11.01% | $723.22M | |
| -42.64% | $1.02B | |
| -53.57% | $1.39B | |
| -50.20% | $847.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Septerna, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Septerna, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Septerna, Inc.'s ROE?
How is the ROE calculated for Septerna, Inc. (SEPN)?
What is the highest ROE for Septerna, Inc. (SEPN)?
What is the 3-year average ROE for Septerna, Inc. (SEPN)?
What is the 5-year average ROE for Septerna, Inc. (SEPN)?
How does the current ROE for Septerna, Inc. (SEPN) compare to its historical average?